Welcome to our dedicated page for Medifast news (Ticker: MED), a resource for investors and traders seeking the latest updates and insights on Medifast stock.
Medifast Inc (MED) provides investors and stakeholders with centralized access to official company announcements and market-moving developments. This resource aggregates all press releases, financial disclosures, and strategic updates from the clinical nutrition leader known for its OPTAVIA® coaching programs and evidence-based weight management solutions.
Users will find chronological updates covering earnings reports, product innovations, leadership changes, and operational milestones. The curated collection serves as both historical record and strategic tool for tracking MED's position in the $250B+ global wellness industry.
Key content categories include quarterly financial results, clinical study publications, partnership announcements, and regulatory filings. All materials are sourced directly from Medifast's investor relations team to ensure accuracy and timeliness.
Bookmark this page for streamlined monitoring of MED's business trajectory, with updates organized to highlight material developments affecting long-term growth in the health solutions sector.
Medifast, Inc. (NYSE: MED) announced it will disclose its financial results for Q2 2021 on August 4, 2021, after market close. The conference call for discussing these results will start at 4:30 p.m. ET on the same day. Participants will include Chairman and CEO Dan Chard, and CFO Jim Maloney. The call will be live-streamed on the company's Investor Relations page and available for playback afterward. Medifast is recognized for its health and wellness brand OPTAVIA® and has been ranked among FORTUNE's 100 Fastest-Growing Companies in 2020.
Medifast has declared a $1.42 quarterly cash dividend for stockholders, payable on August 6, 2021, to those on record by June 22, 2021. The company aims to maintain a quarterly dividend program, subject to Board discretion based on various factors. Medifast, traded on NYSE under the symbol MED, is known for its health and wellness community, OPTAVIA, and has been recognized as one of the 100 Fastest-Growing Companies by Fortune in 2020. Investors should note potential fluctuations in dividend declarations based on corporate performance.
Medifast, Inc. (NYSE: MED) reported exceptional first-quarter results for 2021, showcasing a 90.9% increase in revenue to $340.7 million. Active earning OPTAVIA Coaches grew by 61.0% to 52,500, while revenue per coach jumped 21.0% to $6,454. Net income soared by 122.2% to $41.1 million, resulting in an EPS of $3.46. The company anticipates full-year revenue of $1.4 billion to $1.475 billion and EPS between $12.69 and $14.14. Despite solid performance, the gross profit margin declined slightly to 73.0%.
Medifast, Inc. (NYSE: MED) will announce its first-quarter financial results for the period ending March 31, 2021, on May 4, 2021, after market close. This announcement will be followed by a conference call at 4:30 p.m. ET on the same day, featuring CEO Dan Chard and CFO Jim Maloney. The call will be accessible via the company's Investor Relations page. Medifast is recognized for its OPTAVIA® health and wellness community, known for its scientifically developed products and support system aimed at achieving lifelong transformation.
Medifast, Inc. (NYSE: MED) announced a quarterly cash dividend of $1.42 per share, payable on May 6, 2021 to stockholders of record by March 30, 2021. The company aims to maintain quarterly dividend payments, subject to the Board's discretion based on relevant factors. Medifast operates the OPTAVIA® community, promoting health and wellness through scientifically developed products and coaching. Ranked among FORTUNE's fastest-growing companies, Medifast emphasizes its commitment to shareholder returns.
Medifast, Inc. (NYSE: MED) reported impressive financial results for Q4 and the full year 2020. Q4 revenue surged by 55.3% to $264.9 million, with net income increasing by 40.8% to $28.0 million. The full year revenue reached $934.8 million, up 31.0%, with a net income of $102.9 million. The company also recorded a 42.2% rise in EPS to $2.36 for Q4. Active earning OPTAVIA Coaches grew 39.0% to 44,200, contributing to strong operational momentum despite challenges from the COVID-19 pandemic.
Medifast, Inc. (NYSE: MED) will release its financial results for Q4 and the full year ending December 31, 2020, on February 25, 2021, after market close. A conference call featuring CEO Dan Chard and CFO Jim Maloney will be held at 4:30 p.m. ET on the same day to discuss these results. Investors can listen via the Medifast website or dial in for a telephonic playback available until March 4, 2021. Medifast is recognized as one of the fastest-growing health and wellness companies globally and is listed among FORTUNE's 100 Fastest-Growing Companies in 2020.
Medifast, Inc. (NYSE: MED) announced that CEO Dan Chard and CFO Jim Maloney will present at the 23rd Annual ICR Conference on January 11, 2021. The virtual presentation is scheduled to start at 11:30 a.m. ET and will be streamed live on the company's Investor Relations website, with an archive available until January 25, 2021. Medifast, recognized for its health and wellness community OPTAVIA®, combines decades of experience with a direct selling model to promote healthy habits through a comprehensive support system.
